Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective Study

Background: The effect of lymph node resection after endoscopic treatment of malignant polyps is controversial. Therefore, in this study, we aimed to estimate the potential cancer-specific survival (CSS) benefits of lymphadenectomy in patients undergoing endoscopic resection for colorectal cancer (C...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiangying Deng, Yang Zhang, Xiong Guo, Lin Zhou, Xiangzhou Tan
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Investigative Surgery
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/08941939.2025.2484540
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850142619048345600
author Xiangying Deng
Yang Zhang
Xiong Guo
Lin Zhou
Xiangzhou Tan
author_facet Xiangying Deng
Yang Zhang
Xiong Guo
Lin Zhou
Xiangzhou Tan
author_sort Xiangying Deng
collection DOAJ
description Background: The effect of lymph node resection after endoscopic treatment of malignant polyps is controversial. Therefore, in this study, we aimed to estimate the potential cancer-specific survival (CSS) benefits of lymphadenectomy in patients undergoing endoscopic resection for colorectal cancer (CRC).Methods A total of 6626 patients with CRC who were initially referred for endoscopic polypectomy were enrolled from the Surveillance Epidemiology and End Results Database.Results: Most enrolled patients (6557/6626, 99.0%) were at T0–T1 stage (American Joint Committee on Cancer staging system). Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were used to reduce selection bias, which resulted in balanced groups of patients with and without lymphadenectomy, with no difference in CSS (p = .99 and .074, respectively). In the subgroup analysis, insufficient lymphadenectomy (lymph node yield [LNY] < 12) was associated with poor CSS compared with no lymphadenectomy. The multivariate analysis identified adequate lymphadenectomy with an LNY ≥ 12 as an independent favorable prognostic factor. However, nearly half of the patients (59/127, 46.5%) referred for lymph node resection did not undergo adequate lymphadenectomy.Conclusions The prognosis of CSS cannot be improved by lymphadenectomy for most patients (T0–T1) who are referred for endoscopic therapy because of the low rate of lymph node metastasis. Nonetheless, adequate lymphadenectomy should be performed instead of diagnostic lymph node resection if lymph node involvement is suspected.
format Article
id doaj-art-c1090d9ba68f4ef391c2e19eab21dd96
institution OA Journals
issn 0894-1939
1521-0553
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Investigative Surgery
spelling doaj-art-c1090d9ba68f4ef391c2e19eab21dd962025-08-20T02:29:00ZengTaylor & Francis GroupJournal of Investigative Surgery0894-19391521-05532025-12-0138110.1080/08941939.2025.2484540Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective StudyXiangying Deng0Yang Zhang1Xiong Guo2Lin Zhou3Xiangzhou Tan4Department of General Surgery, Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, P.R. ChinaBackground: The effect of lymph node resection after endoscopic treatment of malignant polyps is controversial. Therefore, in this study, we aimed to estimate the potential cancer-specific survival (CSS) benefits of lymphadenectomy in patients undergoing endoscopic resection for colorectal cancer (CRC).Methods A total of 6626 patients with CRC who were initially referred for endoscopic polypectomy were enrolled from the Surveillance Epidemiology and End Results Database.Results: Most enrolled patients (6557/6626, 99.0%) were at T0–T1 stage (American Joint Committee on Cancer staging system). Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were used to reduce selection bias, which resulted in balanced groups of patients with and without lymphadenectomy, with no difference in CSS (p = .99 and .074, respectively). In the subgroup analysis, insufficient lymphadenectomy (lymph node yield [LNY] < 12) was associated with poor CSS compared with no lymphadenectomy. The multivariate analysis identified adequate lymphadenectomy with an LNY ≥ 12 as an independent favorable prognostic factor. However, nearly half of the patients (59/127, 46.5%) referred for lymph node resection did not undergo adequate lymphadenectomy.Conclusions The prognosis of CSS cannot be improved by lymphadenectomy for most patients (T0–T1) who are referred for endoscopic therapy because of the low rate of lymph node metastasis. Nonetheless, adequate lymphadenectomy should be performed instead of diagnostic lymph node resection if lymph node involvement is suspected.https://www.tandfonline.com/doi/10.1080/08941939.2025.2484540Colorectal cancerendoscopymalignant neoplasmslymph node excisioncolonic polyps
spellingShingle Xiangying Deng
Yang Zhang
Xiong Guo
Lin Zhou
Xiangzhou Tan
Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective Study
Journal of Investigative Surgery
Colorectal cancer
endoscopy
malignant neoplasms
lymph node excision
colonic polyps
title Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective Study
title_full Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective Study
title_fullStr Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective Study
title_full_unstemmed Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective Study
title_short Lymphadenectomy Does Not Improve Cancer-Specific Survival for Colorectal Cancer Patients Underwent Endoscopic Therapy: A Population-Based Retrospective Study
title_sort lymphadenectomy does not improve cancer specific survival for colorectal cancer patients underwent endoscopic therapy a population based retrospective study
topic Colorectal cancer
endoscopy
malignant neoplasms
lymph node excision
colonic polyps
url https://www.tandfonline.com/doi/10.1080/08941939.2025.2484540
work_keys_str_mv AT xiangyingdeng lymphadenectomydoesnotimprovecancerspecificsurvivalforcolorectalcancerpatientsunderwentendoscopictherapyapopulationbasedretrospectivestudy
AT yangzhang lymphadenectomydoesnotimprovecancerspecificsurvivalforcolorectalcancerpatientsunderwentendoscopictherapyapopulationbasedretrospectivestudy
AT xiongguo lymphadenectomydoesnotimprovecancerspecificsurvivalforcolorectalcancerpatientsunderwentendoscopictherapyapopulationbasedretrospectivestudy
AT linzhou lymphadenectomydoesnotimprovecancerspecificsurvivalforcolorectalcancerpatientsunderwentendoscopictherapyapopulationbasedretrospectivestudy
AT xiangzhoutan lymphadenectomydoesnotimprovecancerspecificsurvivalforcolorectalcancerpatientsunderwentendoscopictherapyapopulationbasedretrospectivestudy